Clinical Trial Update: Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing catheter cryoablation to antiarrhythmic drugs as first-line therapy for symptomatic paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Antiarrhythmic drugs (various)

Snippet

Sponsor: Medtronic Cardiac Ablation Solutions | Conditions: Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases | Phase 4 | Status: COMPLETED